- Home
- BDRX vs APDN Comparison
BDRX vs APDN Comparison
Compare BDRX & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- APDN
- Stock Information
- Founded
- BDRX 2000
- APDN 1983
- Country
- BDRX United Kingdom
- APDN United States
- Employees
- BDRX N/A
- APDN N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- BDRX Health Care
- APDN Consumer Discretionary
- Exchange
- BDRX Nasdaq
- APDN Nasdaq
- Market Cap
- BDRX 3.5M
- APDN 2.0M
- IPO Year
- BDRX N/A
- APDN N/A
- Fundamental
- Price
- BDRX $1.48
- APDN $0.85
- Analyst Decision
- BDRX
- APDN Strong Buy
- Analyst Count
- BDRX 0
- APDN 1
- Target Price
- BDRX N/A
- APDN $75.00
- AVG Volume (30 Days)
- BDRX 1.2M
- APDN 1.5M
- Earning Date
- BDRX 05-09-2025
- APDN 05-09-2025
- Dividend Yield
- BDRX N/A
- APDN N/A
- EPS Growth
- BDRX N/A
- APDN N/A
- EPS
- BDRX N/A
- APDN N/A
- Revenue
- BDRX N/A
- APDN $3,736,873.00
- Revenue This Year
- BDRX N/A
- APDN $57.08
- Revenue Next Year
- BDRX N/A
- APDN $40.00
- P/E Ratio
- BDRX N/A
- APDN N/A
- Revenue Growth
- BDRX N/A
- APDN N/A
- 52 Week Low
- BDRX $1.14
- APDN $0.72
- 52 Week High
- BDRX $74.00
- APDN $246.00
- Technical
- Relative Strength Index (RSI)
- BDRX 41.93
- APDN 22.68
- Support Level
- BDRX $1.24
- APDN $0.72
- Resistance Level
- BDRX $1.65
- APDN $0.95
- Average True Range (ATR)
- BDRX 0.20
- APDN 0.14
- MACD
- BDRX 0.06
- APDN 0.17
- Stochastic Oscillator
- BDRX 38.10
- APDN 15.44
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.